CL
Cellebration Life Sciences specializes in research and treatment methodologies for autoimmune diseases and orthopedic injuries, utilizing advanced cellular therapies and regenerative medicine techniques. The company aims to improve patient outcomes by providing targeted interventions that enhance recovery and reduce chronic pain associated with these conditions.
Updated 4 months ago
Funding
$2.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Cellebration Life Sciences specializes in research and treatment methodologies for autoimmune diseases and orthopedic injuries, utilizing advanced cellular therapies and regenerative medicine techniques. The company aims to improve patient outcomes by providing targeted interventions that enhance recovery and reduce chronic pain associated with these conditions.